Corvus Pharmaceuticals

CRVSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.171 B

$13.92 +0.43%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$15.3M

Loss-making

Shares outstanding

84,120,944

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#151Wave Life SciencesWVE$1.20B
#152SavaraSVRA$1.19B
#153Corvus PharmaceuticalsCRVS$1.17B
#154InventivaIVA$1.13B
#155Alto NeuroscienceANRO$1.11B

Where these numbers come from

Share counts and financials for Corvus Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.